Halozyme Therapeutics, Inc. (HALO) Posts Q1 Loss of 22c/Share

Go back to Halozyme Therapeutics, Inc. (HALO) Posts Q1 Loss of 22c/Share
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 112.45 --0 (-0%)
Previous Close $112.45    52 Week High $18.39 
Open $112.45    52 Week Low $6.96 
Day High $112.45    P/E N/A 
Day Low $112.45    EPS $-0.58 
Volume 2,284